Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 896.40 INR
Change Today 0.00 / 0.00%
Volume 0.0
GNP On Other Exchanges
Symbol
Exchange
Natl India
OTC US
As of 7:06 AM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Glenn Mario Saldanha

Chairman of The Board, Chief Executive Officer, Managing Director, Member of Nomination & Remuneration Committee and Member of Shareholders/Investors Grievance Committee, Glenmark Pharmaceuticals Ltd.
AgeTotal Calculated CompensationThis person is connected to 13 board members in 3 different organizations across 4 different industries.

See Board Relationships
4472,725,749
As of Fiscal Year 2014

Background*

Mr. Glenn Mario Saldanha has been the Managing Director and Chief Executive Officer of Glenmark Pharmaceuticals Ltd. since 2001. Mr. Saldanha serves as the Chief Executive Officer of Glenmark Pharmaceuticals S.A. He has worked for Eli Lilly in the U.S and was a Management Consultant with Price Waterhouse Coopers. His Services have been used by Smithkline Beecham, Rhone Poulenc Rhorer, Astra, Merck and Johnson and Johnson, among others. He has 15 years of experience in ...

Read Full Background

Corporate Headquarters*

Glenmark House
Mumbai, Maharashtra 400099

India

Phone: 91 22 4018 9999
Fax: 91 22 4018 9990

Board Members Memberships*

Chief Executive Officer and Director
Chairman and Member of Compensation Committee
1998-Present
Chairman of The Board, Chief Executive Officer, Managing Director, Member of Nomination & Remuneration Committee and Member of Shareholders/Investors Grievance Committee
2009-2011
Former Independent Director

Education*

MBA
New York University - Leonard N. Stern School of Business
Bachelor's Degree
University of Mumbai

Other Affiliations*

Annual Compensation*

Salary57,104,506
Total Annual Compensation57,104,506

Stock Options*

All Other Compensation15,621,243

Total Compensation*

Total Annual Cash Compensation72,725,749
Total Short Term Compensation57,104,506
Other Long Term Compensation15,621,243
Total Calculated Compensation72,725,749
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GNP:IN 896.40 INR 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
George Frederick Wilkinson Chief Executive Officer, President and Director
Impax Laboratories Inc.
$552.5K
Pankaj R. Patel M.PharmChairman, Managing Director, Chairman of Share Transfer Committee, Chairman of Committee of Directors and Member of Shareholders'/Investors' Grievance Committee
Cadila Healthcare Limited
--
Arthur P. Bedrosian J.D.Chief Executive Officer, Director and Chairman of Strategic Planning Committee
Lannett Company, Inc.
$539.0K
Hari Shankar Bhartia Co-Chairman, Managing Director, Chairman of Corporate Governance Committee, Member of Compensation Committee, Member of Fund Raising Committee, Member of Finance Committee and Member of Sustainability & CSR Committee
Jubilant Life Sciences Limited
--
Vivek Dhawan Chief Executive Officer, Director and Member of Remuneration and Nomination Committee
Mega Lifesciences Public Company Limited
--
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLENMARK PHARMACEUTICALS LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.